SCHEMBL22050053

SCHEMBL22050053

CC1COCC12CCNCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13952185 1.00 — —
SCHEMBL16659520 0.79 — —
Water SCHEMBL8832205 0.76 — —
SCHEMBL27094637 0.75 — —
SCHEMBL24703609 0.74 PTPN11 (0.32) —
SCHEMBL14108539 0.74 — —
SCHEMBL20954120 0.74 PTPN11 (0.32) —
SCHEMBL18328259 0.74 PTPN11 (0.32) —
SCHEMBL13931091 0.74 — —
SCHEMBL25646842 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4289823-A1 SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES Medshine Discovery Inc. (CN) 2023-12-13 — — EP disclosed
US-20200172546-A1 PYRAZOLO[3,4-B]PYRAZINE DERIVATIVES AS SHP2 PHOSPHATASE INHIBITORS RELAY THERAPEUTICS, INC. 2020-06-04 — — US disclosed
Send feedback